Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Stern

Showing results (41-50 of 139) with videos related to

Pageof 14
Sort By:
Clinical Neuropharmacology|August 1, 1990
Apomorphine in the diagnosis and treatment of parkinsonian tremorA J Hughes, A J Lees, G M Stern
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1984
Kinesigenic foot dystonia as a presenting feature of Parkinson's diseaseA J Lees, R J Hardie, G M Stern
Clinical Neuropharmacology|January 1, 1986
Treatment of motor fluctuations in Parkinson's disease with an oral sustained-release preparation of L-dopa: clinical and pharmacokinetic observationsW H Poewe, A J Lees, G M Stern
European Neurology|January 1, 1987
Clinical and pharmacokinetic observations with Madopar HBS in hospitalized patients with Parkinson's disease and motor fluctuationsW H Poewe, A J Lees, G M Stern
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1978
Baclofen in Parkinson's diseaseA J Lees, K M Shaw, G M Stern
Lancet (London, England)|December 19, 1970
Use of levodopa with other drugsK R Hunter, G M Stern, D R Laurence
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1991
The motor response to sequential apomorphine in parkinsonian fluctuationsA J Hughes, A J Lees, G M Stern
British Journal of Pharmacology|August 1, 1990
The effect of benserazide on the peripheral and central distribution and metabolism of levodopa after acute and chronic administration in the ratA P Kent, G M Stern, R A Webster
Clinical Neuropharmacology|January 1, 1985
The controversial role of bromocriptine in Parkinson's diseaseR J Hardie, A J Lees, G M Stern
Lancet (London, England)|December 2, 1978
Tiapride and sulpiride in Parkinson's diseaseA J Lees, C M Lander, G M Stern
Pageof 14

Showing results (41-50 of 139) with videos related to

Sort By:
Pageof 14
Clinical Neuropharmacology|August 1, 1990
Apomorphine in the diagnosis and treatment of parkinsonian tremorA J Hughes, A J Lees, G M Stern
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1984
Kinesigenic foot dystonia as a presenting feature of Parkinson's diseaseA J Lees, R J Hardie, G M Stern
Clinical Neuropharmacology|January 1, 1986
Treatment of motor fluctuations in Parkinson's disease with an oral sustained-release preparation of L-dopa: clinical and pharmacokinetic observationsW H Poewe, A J Lees, G M Stern
European Neurology|January 1, 1987
Clinical and pharmacokinetic observations with Madopar HBS in hospitalized patients with Parkinson's disease and motor fluctuationsW H Poewe, A J Lees, G M Stern
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1978
Baclofen in Parkinson's diseaseA J Lees, K M Shaw, G M Stern
Lancet (London, England)|December 19, 1970
Use of levodopa with other drugsK R Hunter, G M Stern, D R Laurence
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1991
The motor response to sequential apomorphine in parkinsonian fluctuationsA J Hughes, A J Lees, G M Stern
British Journal of Pharmacology|August 1, 1990
The effect of benserazide on the peripheral and central distribution and metabolism of levodopa after acute and chronic administration in the ratA P Kent, G M Stern, R A Webster
Clinical Neuropharmacology|January 1, 1985
The controversial role of bromocriptine in Parkinson's diseaseR J Hardie, A J Lees, G M Stern
Lancet (London, England)|December 2, 1978
Tiapride and sulpiride in Parkinson's diseaseA J Lees, C M Lander, G M Stern
Pageof 14